Search Results 1141-1150 of 18472 for prednisone
Immunodeficiency or immunosuppression, including systemic corticosteroids at \>10 mg/day prednisone or equivalent within 1 week prior to planned start of study ...
Subject is taking >20mg prednisone (or equivalent dose of a similar steroid) daily. Subject requires high level chronic immunomodulatory therapy to treat a ...
Use of systemic or topical corticosteroids exceeding the equivalent of 10 mg/day of prednisone within 4 weeks prior to the screening visit. Change in the ...
... prednisone within 3 months prior to screening or anticipated during the study period; Pulmonary tuberculosis requiring treatment or treated within 2 years ...
Use of a systemic steroid (> 5 mg prednisone daily or equivalent) ≤ 4 weeks prior to registration. Pregnancy. Persons of childbearing potential must have a ...
... prednisone or equivalent. Participant has an active or past medical history of interstitial lung disease (ILD)/pneumonitis, including drug-induced or ...
Palliative steroids must be at a dose not higher than 20 mg/day of prednisone or equivalent corticosteroid at the time of registration. ... Patients must not ...
Use of systemic corticosteroids within 2 weeks, except low dose regimens (prednisone, <20 mg/day, or equivalent) which may continue if unchanged. Prior ...
Primary or secondary immunodeficiency, including immunosuppressive disease, and immunosuppressive doses of corticosteroids (e.g., prednisone > 20 mg per day ...
This relaxes the blood vessels and lowers blood pressure. A lower blood pressure will increase the supply of blood and oxygen to the heart. This medicine is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!